Institute of Cognitive Neuroscience, Faculty of Education, Huaibei Normal University, Huaibei, China.
Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Canada.
Brain Behav Immun. 2020 Jul;87:40-48. doi: 10.1016/j.bbi.2020.04.028. Epub 2020 Apr 13.
In addition to being a public physical health emergency, Coronavirus disease 2019 (COVID-19) affected global mental health, as evidenced by panic-buying worldwide as cases soared. Little is known about changes in levels of psychological impact, stress, anxiety and depression during this pandemic. This longitudinal study surveyed the general population twice - during the initial outbreak, and the epidemic's peak four weeks later, surveying demographics, symptoms, knowledge, concerns, and precautionary measures against COVID-19. There were 1738 respondents from 190 Chinese cities (1210 first-survey respondents, 861 s-survey respondents; 333 respondents participated in both). Psychological impact and mental health status were assessed by the Impact of Event Scale-Revised (IES-R) and the Depression, Anxiety and Stress Scale (DASS-21), respectively. IES-R measures PTSD symptoms in survivorship after an event. DASS -21 is based on tripartite model of psychopathology that comprise a general distress construct with distinct characteristics. This study found that there was a statistically significant longitudinal reduction in mean IES-R scores (from 32.98 to 30.76, p < 0.01) after 4 weeks. Nevertheless, the mean IES-R score of the first- and second-survey respondents were above the cut-off scores (>24) for PTSD symptoms, suggesting that the reduction in scores was not clinically significant. During the initial evaluation, moderate-to-severe stress, anxiety and depression were noted in 8.1%, 28.8% and 16.5%, respectively and there were no significant longitudinal changes in stress, anxiety and depression levels (p > 0.05). Protective factors included high level of confidence in doctors, perceived survival likelihood and low risk of contracting COVID-19, satisfaction with health information, personal precautionary measures. As countries around the world brace for an escalation in cases, Governments should focus on effective methods of disseminating unbiased COVID-19 knowledge, teaching correct containment methods, ensuring availability of essential services/commodities, and providing sufficient financial support.
除了是一种公共卫生紧急情况外,2019 年冠状病毒病(COVID-19)还对全球心理健康产生了影响,因为随着病例的飙升,世界各地都出现了恐慌性购买。在这种大流行期间,人们对心理影响、压力、焦虑和抑郁水平的变化知之甚少。这项纵向研究在疫情爆发初期和四周后的高峰期两次对普通人群进行了调查,调查了人口统计学、症状、知识、关注和针对 COVID-19 的预防措施。来自中国 190 个城市的 1738 名受访者(1210 名第一调查受访者,861 名第二次调查受访者;333 名受访者同时参加了两次调查)。心理影响和心理健康状况分别通过修订后的事件影响量表(IES-R)和抑郁、焦虑和压力量表(DASS-21)进行评估。IES-R 衡量事件发生后幸存者的创伤后应激障碍症状。DASS -21 基于精神病理学的三分模型,包括具有独特特征的一般困扰结构。这项研究发现,4 周后,IES-R 平均评分(从 32.98 降至 30.76,p<0.01)呈统计学显著纵向降低。尽管如此,第一和第二次调查受访者的 IES-R 平均得分高于创伤后应激障碍症状的临界分数(>24),这表明评分的降低没有临床意义。在初步评估中,中度至重度压力、焦虑和抑郁分别为 8.1%、28.8%和 16.5%,压力、焦虑和抑郁水平没有显著的纵向变化(p>0.05)。保护因素包括对医生的高度信心、感知生存可能性和感染 COVID-19 的低风险、对健康信息的满意度、个人预防措施。随着世界各地的病例数量不断增加,各国政府应重点关注有效传播公正的 COVID-19 知识、教授正确的遏制方法、确保基本服务/商品的供应以及提供充足的财政支持。